Search results
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Find inspiration and motivation for staying active, eating healthy, and building up your knowledge with resources and education from NovoCare. Apply for the Novo Nordisk Patient Assistance Program (PAP) to see if you qualify to receive your Novo Nordisk diabetes medicine at no cost.
Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. [ 5] Its main product is the drug semaglutide, used to treat diabetes under the brand names Ozempic and Rybelsus and obesity under the brand name Wegovy. [ 6]
Find the latest Novo Nordisk A/S (NVO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in discovering and developing treatment for serious chronic disease, like diabetes and obesity.
At Novo Nordisk, you will have the opportunity to build a life-changing career in a global business environment. Join us and make a difference.
Novo Nordisk was named as the Best Place in the World to Work in 2022, but our people are what make our company what it is today, and will continue to shape our future. Discovering novel therapies to treat chronic disease for over 100 years. Learn who we are.
Apr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
Learn about the Novo Nordisk Patient Assistance Program (PAP) for people with diabetes and find out if your patients qualify to receive medication at no cost.